---
figid: PMC9509630__12967_2022_3631_Fig1_HTML
figtitle: 'Potential impact of a probiotic: Akkermansia muciniphila in the regulation
  of blood pressure—the current facts and evidence'
organisms:
- Akkermansia muciniphila
- Escherichia coli
- Salmonella enterica subsp. enterica serovar Typhimurium
- Salmonella enterica
- Faecalibacterium prausnitzii
- Lacticaseibacillus paracasei
- Loigolactobacillus coryniformis
- Akkermansia glycaniphila
- Candida dubliniensis
- Hordeum vulgare
- Olea europaea
- Punica granatum
- Plukenetia volubilis
- gut metagenome
- metagenome
- human gut metagenome
- human metagenome
- Mus musculus
- Rattus norvegicus
- Mus musculus domesticus
- Homo sapiens
- Sus scrofa
- Malayopython reticulatus
- NA
pmcid: PMC9509630
filename: 12967_2022_3631_Fig1_HTML.jpg
figlink: /pmc/articles/PMC9509630/figure/Fig1/
number: F1
caption: Schematic representation of the possible mechanism of action of A. muciniphila
  on the control of BP. The potential possible mechanisms of A. muciniphila to control
  the BP are (1) the degradation of mucin to secrete the SCFAs, especially acetate
  and propionate that reduces plasma leptin secretion and sympathetic activity through
  the secretion of GLP-1/GLP-2 in enteroendocrine L-cells via G-protein-coupled receptors;
  (2) maintenance of gut barrier integrity through the regulation of the tight junctions
  proteins (occludins, claudins, zona occludens), and activation of TLR2 pathway through
  the reduction of LPS synthesis and inflammatory markers; (3) utilization of H2S
  to produce cysteine which improves the BP; (4) direct action (possibly) on the renin-angiotensin-II
  pathway, and (5) reduction of oxidative stress induced by TMAO through the dietary
  L-carnitine metabolite
papertitle: 'The potential impact of a probiotic: Akkermansia muciniphila in the regulation
  of blood pressure—the current facts and evidence.'
reftext: Arun Prasath Lakshmanan, et al. J Transl Med. 2022;20:430.
year: '2022'
doi: 10.1186/s12967-022-03631-0
journal_title: Journal of Translational Medicine
journal_nlm_ta: J Transl Med
publisher_name: BioMed Central
keywords: Akkermansia muciniphila | Hypertension | Gut microbiome | Metagenomic |
  Blood pressure | Gut microbiota
automl_pathway: 0.6921104
figid_alias: PMC9509630__F1
figtype: Figure
organisms_ner:
- Sus scrofa
- Mus musculus
redirect_from: /figures/PMC9509630__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9509630__12967_2022_3631_Fig1_HTML.html
  '@type': Dataset
  description: Schematic representation of the possible mechanism of action of A.
    muciniphila on the control of BP. The potential possible mechanisms of A. muciniphila
    to control the BP are (1) the degradation of mucin to secrete the SCFAs, especially
    acetate and propionate that reduces plasma leptin secretion and sympathetic activity
    through the secretion of GLP-1/GLP-2 in enteroendocrine L-cells via G-protein-coupled
    receptors; (2) maintenance of gut barrier integrity through the regulation of
    the tight junctions proteins (occludins, claudins, zona occludens), and activation
    of TLR2 pathway through the reduction of LPS synthesis and inflammatory markers;
    (3) utilization of H2S to produce cysteine which improves the BP; (4) direct action
    (possibly) on the renin-angiotensin-II pathway, and (5) reduction of oxidative
    stress induced by TMAO through the dietary L-carnitine metabolite
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TLR2
  - FFAR2
  - HCAR2
  - GCG
  - RIOX2
  - H2-S
  - Tlr4
  - Tlr2
  - Gusb
  - Ffar3
  - Ffar2
  - Hcar2
  - Or51e2
  - Glp2r
  - Gcg
  - Lce1l
  - Cd36
  - Cpe
  - Riox2
---
